An FDA analysis of Johnson & Johnson’s vaccine released Wednesday found that it was safe and effective. A study reported that the vaccine protected against COVID-19 at a rate of about 66% against symptomatic cases and 85% against severe cases. After 28 days following vaccination, there were zero cases of hospitalizations or deaths.

